Silver Price Forecast: XAG/USD bulls await acceptance above $66.00, 100-day EMA breakout
Silver (XAG/USD) is seen building on Friday's bounce from mid-$63.00s and gaining some follow-through positive traction at the start of a new week. The white metal, however, continues with its struggle to break above the 100-day Exponential Moving Average (EMA) and currently trades above mid-$65.00s, up around 1.50% for the day.
The US Dollar (USD) selling bias remains unabated as traders continue to scale back Federal Reserve (Fed) rate hike bets amid signs of cooling US inflation and weak consumer spending. This, in turn, is seen as a key factor underpinning demand for USD-denominated commodities, including the XAG/USD, and backs the case for further gains.
From a broader technical perspective, the XAG/USD has been oscillating in a familiar range over the past week or so. This could be categorized as a bullish consolidation phase against the backdrop of a goodish recovery from the year-to-date low, touched in July, and the recent breakout through the 23.6% Fibonacci retracement level of the May-July downfall.
Moreover, momentum indicators stay constructive as the Relative Strength Index (RSI) hovers near 61, and the Moving Average Convergence Divergence (MACD) histogram holds in positive territory. This suggests that upside attempts could persist even as the XAG/USD struggles to make it through the 100-day EMA pivotal resistance near the $66.33 area.
The said barrier is followed by the 38.2% Fibo. level at $67.93. A sustained move above the said levels would be needed to pave the way for further gains toward the mid-range Fibonacci hurdle at $72.02. On the downside, initial support is aligned with the 23.6% Fibo. near $62.87, where a break would expose the lower anchor of the current swing near $54.70.
XAG/USD daily chart
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RIGEL PHARMACEUTICALS, INC. <RIGL.O>: PIPER SANDLER RAISES TARGET PRICE TO $49 FROM $40
BERKSHIRE HATHAWAY <BRKb.N>: TD COWEN RAISES TARGET PRICE TO $529 FROM $481
BERKSHIRE HATHAWAY <BRKa.N>: TD COWEN RAISES TARGET PRICE TO $792,000 FROM $721,000
Sol Strategies FY26 Q3 net loss widens to CAD 119.36 million; revenue falls to CAD 5.04 million
